Related Experiment Video
Updated: May 10, 2026

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
Identification of submicroscopic genetic changes and precise breakpoint mapping in myelofibrosis using high
Terra Lasho1, Sarah H Johnson, David I Smith
1Mayo College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
American Journal of Hematology
|June 5, 2013
Summary
High-resolution mate-pair sequencing identified novel genetic alterations in primary myelofibrosis (PMF). This study highlights the genetic heterogeneity of PMF and the utility of advanced sequencing for uncovering complex genomic rearrangements.
Area of Science:
- Genomics
- Molecular Biology
- Hematology
Background:
- Primary myelofibrosis (PMF) is a complex myeloproliferative neoplasm with a heterogeneous genetic landscape.
- Accurate characterization of genetic abnormalities is crucial for understanding PMF pathogenesis and developing targeted therapies.
Purpose of the Study:
- To utilize high-resolution mate-pair sequencing (HRMPS) to identify novel submicroscopic deletions, translocations, and fusion transcripts in patients with PMF.
- To precisely map translocation breakpoints in PMF patients with known cytogenetic abnormalities.
Main Methods:
- High-resolution mate-pair sequencing (HRMPS) was performed on 15 patients with primary myelofibrosis.
- Polymerase chain reaction (PCR) was used to validate identified breakpoints.
- Fusion transcript analysis was conducted.
Main Results:
- Seven novel deletions/translocations were identified in five patients, involving genes such as MACROD2, CACNA2D4, and TET2.
- Recurrent deletions involving MACROD2 were observed in two patients.
- A novel INTS3-CHTOP fusion transcript was detected in one patient and an additional PMF patient.
- Precise breakpoints for der(6)t(1;6) translocations were mapped, involving KCNN3, GUSBP2, and HYDIN2.
Conclusions:
- HRMPS is effective in detecting submicroscopic genomic alterations and precisely mapping breakpoints in PMF.
- The findings confirm the significant genetic heterogeneity of PMF.
- Further investigation into the pathogenetic relevance of the identified alterations is warranted.

